Matches in SemOpenAlex for { <https://semopenalex.org/work/W2412620152> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W2412620152 abstract "Background Current clinical practice guidelines for acute coronary syndrome recommend that patients should receive dual antiplatelet treatment with acetylsalicylic acid and an ADP receptor inhibitor for 12 months. Today, two novel P2Y12 receptor inhibitors, prasugrel and ticagrelor, have been developed that offer more effective and faster platelet inhibition than clopidogrel. Current guidelines recommend that these compounds should be used in preference to clopidogrel in a wide range of patients. Purpose To assess the prescription profile of novel oral antiplatelet agents for acute coronary syndrome in the cardiology department of a tertiary hospital. Correlation with present guidelines of the European Society of Cardiology. Material and methods Retrospective descriptive study over a 5 year period (January 2010 to April 2015). The percentage of patients treated with clopidogrel, prasugrel or ticagrelor was calculated with respect to the total number of patients treated with any P2Y12 receptor inhibitor. Results Prescription profile has been changing since the new antiplatelet agents were authorised (prasugrel in 2009, ticagrelor in 2011). Clopidogrel: 96% in 2011, 94% in 2012, 96% in 2013, 80% in 2014 and 71% in 2015. Prasugrel: 4% in 2011, 6% in 2012, 1% in 2013 and 5% in 2014–2015. Ticagrelor: 3% in 2013, 15% in 2014 and 24% in 2015. A progressive increase in ticagrelor prescription to the detriment of clopidogrel was observed. Prasugrel prescription is low and constant. Clopidogrel is the most prescribed antiplatelet in this unit although guidelines recommend its use only in patients who cannot receive ticagrelor or prasugrel or who require oral anticoagulation (IB), and patients who receive fibrinolytic therapy. Conclusion Paradoxically new oral antiplatelet agents are used infrequently. An increase in ticagrelor prescription is expected as it is recommended as the first option for all patients at moderate to high risk of ischaemic events regardless of the initial treatment strategy and including those pretreated with clopidogrel (IB). Prasugrel has been shown to have greater clinical benefits than clopidogrel in patients who have undergone percutaneous coronary interventions (IB) but several restrictions limit it use compared with ticagrelor. The development of standard clinical protocols would help improve the quality of care. References and/or Acknowledgement 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST segment elevation. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST segment elevation. No conflict of interest." @default.
- W2412620152 created "2016-06-24" @default.
- W2412620152 creator A5026232945 @default.
- W2412620152 creator A5029135402 @default.
- W2412620152 creator A5033055030 @default.
- W2412620152 creator A5062695409 @default.
- W2412620152 creator A5066012872 @default.
- W2412620152 creator A5068926283 @default.
- W2412620152 creator A5073754705 @default.
- W2412620152 creator A5081310051 @default.
- W2412620152 creator A5084973058 @default.
- W2412620152 date "2016-02-14" @default.
- W2412620152 modified "2023-10-17" @default.
- W2412620152 title "DI-028 Novel oral antiplatelet agents in acute coronary syndrome. Prescription profile in a tertiary hospital" @default.
- W2412620152 doi "https://doi.org/10.1136/ejhpharm-2016-000875.295" @default.
- W2412620152 hasPublicationYear "2016" @default.
- W2412620152 type Work @default.
- W2412620152 sameAs 2412620152 @default.
- W2412620152 citedByCount "0" @default.
- W2412620152 crossrefType "journal-article" @default.
- W2412620152 hasAuthorship W2412620152A5026232945 @default.
- W2412620152 hasAuthorship W2412620152A5029135402 @default.
- W2412620152 hasAuthorship W2412620152A5033055030 @default.
- W2412620152 hasAuthorship W2412620152A5062695409 @default.
- W2412620152 hasAuthorship W2412620152A5066012872 @default.
- W2412620152 hasAuthorship W2412620152A5068926283 @default.
- W2412620152 hasAuthorship W2412620152A5073754705 @default.
- W2412620152 hasAuthorship W2412620152A5081310051 @default.
- W2412620152 hasAuthorship W2412620152A5084973058 @default.
- W2412620152 hasConcept C126322002 @default.
- W2412620152 hasConcept C164705383 @default.
- W2412620152 hasConcept C2426938 @default.
- W2412620152 hasConcept C2777028646 @default.
- W2412620152 hasConcept C2777628954 @default.
- W2412620152 hasConcept C2777698277 @default.
- W2412620152 hasConcept C2777849778 @default.
- W2412620152 hasConcept C2780890252 @default.
- W2412620152 hasConcept C49059817 @default.
- W2412620152 hasConcept C500558357 @default.
- W2412620152 hasConcept C71924100 @default.
- W2412620152 hasConcept C98274493 @default.
- W2412620152 hasConceptScore W2412620152C126322002 @default.
- W2412620152 hasConceptScore W2412620152C164705383 @default.
- W2412620152 hasConceptScore W2412620152C2426938 @default.
- W2412620152 hasConceptScore W2412620152C2777028646 @default.
- W2412620152 hasConceptScore W2412620152C2777628954 @default.
- W2412620152 hasConceptScore W2412620152C2777698277 @default.
- W2412620152 hasConceptScore W2412620152C2777849778 @default.
- W2412620152 hasConceptScore W2412620152C2780890252 @default.
- W2412620152 hasConceptScore W2412620152C49059817 @default.
- W2412620152 hasConceptScore W2412620152C500558357 @default.
- W2412620152 hasConceptScore W2412620152C71924100 @default.
- W2412620152 hasConceptScore W2412620152C98274493 @default.
- W2412620152 hasLocation W24126201521 @default.
- W2412620152 hasOpenAccess W2412620152 @default.
- W2412620152 hasPrimaryLocation W24126201521 @default.
- W2412620152 hasRelatedWork W105670702 @default.
- W2412620152 hasRelatedWork W1639292827 @default.
- W2412620152 hasRelatedWork W2083626455 @default.
- W2412620152 hasRelatedWork W2105297043 @default.
- W2412620152 hasRelatedWork W2135505444 @default.
- W2412620152 hasRelatedWork W2153087016 @default.
- W2412620152 hasRelatedWork W2154294798 @default.
- W2412620152 hasRelatedWork W2167341647 @default.
- W2412620152 hasRelatedWork W2186900752 @default.
- W2412620152 hasRelatedWork W2254524041 @default.
- W2412620152 hasRelatedWork W2293807172 @default.
- W2412620152 hasRelatedWork W2313662773 @default.
- W2412620152 hasRelatedWork W2317433632 @default.
- W2412620152 hasRelatedWork W2417631447 @default.
- W2412620152 hasRelatedWork W2585688399 @default.
- W2412620152 hasRelatedWork W2782819296 @default.
- W2412620152 hasRelatedWork W2902542931 @default.
- W2412620152 hasRelatedWork W3010138828 @default.
- W2412620152 hasRelatedWork W3114573885 @default.
- W2412620152 hasRelatedWork W3139395968 @default.
- W2412620152 isParatext "false" @default.
- W2412620152 isRetracted "false" @default.
- W2412620152 magId "2412620152" @default.
- W2412620152 workType "article" @default.